FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology and molecular biology. Disclosed is a vector genome based on adeno-associated virus (AAV) for delivering a nucleotide sequence encoding decarboxylase of aromatic L-amino acids (AADC) into a cell.
EFFECT: invention can be used for treating Parkinson's disease.
24 cl, 10 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) | 2015 |
|
RU2716422C2 |
MODULATING POLYNUCLEOTIDES | 2015 |
|
RU2749882C2 |
MODULATING POLYNUCLEOTIDES | 2015 |
|
RU2719192C2 |
GENE THERAPY OF OPHTHALMIC DISORDERS | 2016 |
|
RU2762747C2 |
COMPOSITIONS AND METHODS OF TREATING AND PREVENTING MACULAR DEGENERATION | 2015 |
|
RU2703145C2 |
RNAi AGENT OPTION | 2018 |
|
RU2789647C2 |
METHODS FOR TREATMENT OF DANON'S DISEASE AND OTHER AUTOPHAGY DISORDERS | 2017 |
|
RU2777571C2 |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISORDERS AND DISEASES RELATED TO RDH12 | 2017 |
|
RU2764920C2 |
GENE EDITING OF DEEP INTRON MUTATIONS | 2016 |
|
RU2759335C2 |
COMPOSITIONS, METHODS AND APPLICATIONS OF GENE TRANSFER FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2017 |
|
RU2805606C2 |
Authors
Dates
2020-03-17—Published
2015-11-05—Filed